Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KARTHIK KUPPUSAMY Insider Profile
4 Followers
KARTHIK KUPPUSAMY, SVP, Clinical Solutions at Quest Diagnostics, holds 11.66K shares in Quest Diagnostics (Ticker: DGX). Most recently, KARTHIK KUPPUSAMY Sold $1,775 shares of Quest Diagnostics on Oct 30, 2024 for an estimated value of 278.52K.
KARTHIK KUPPUSAMY has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of KARTHIK KUPPUSAMY's holdings
Insider Roles
SVP, Clinical Solutions
Roles that KARTHIK KUPPUSAMY holds in companies
Most Profitable Insider Trade
The most profitable trade made by KARTHIK KUPPUSAMY
KARTHIK KUPPUSAMY's Trading History
List of latest transactions for each holding click on a transaction to see KARTHIK KUPPUSAMY's performance on stock
You May Also Like
KARTHIK KUPPUSAMY insider profile FAQ
What is the percentage of profitable transactions made by KARTHIK KUPPUSAMY?
The percentage of profitable transactions made by KARTHIK KUPPUSAMY is ―.
What is the average return per transaction made by KARTHIK KUPPUSAMY?
The average return per transaction made by KARTHIK KUPPUSAMY is ―.
What stocks does KARTHIK KUPPUSAMY hold?
KARTHIK KUPPUSAMY holds: DGX stocks.
What was KARTHIK KUPPUSAMY’s latest transaction?
KARTHIK KUPPUSAMY latest transaction was an Informative Sell of $278.52K.
What was KARTHIK KUPPUSAMY's most profitable transaction?
KARTHIK KUPPUSAMY’s most profitable transaction was an Informative Sell of DGX stock on October 30, 2024. The return on the trade was -0.90%.
What is KARTHIK KUPPUSAMY's role in Quest Diagnostics?
KARTHIK KUPPUSAMY's role in Quest Diagnostics is SVP, Clinical Solutions.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.